|

Idecabtagene vicleucel Clinical Trials

3 actively recruiting trials across 1 location

Top Sponsors

  • Bristol-Myers Squibb2
  • St. Olavs Hospital1

Indications

  • Cancer3
  • Multiple Myeloma2
  • Chronic Lymphocytic Leukaemia1
  • Myeloma, Multiple1
  • AL Amyloidosis1

Other2 trials

A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
The Norwegian Immunotherapy in Multiple Myeloma Study

Portland, Oregon1 trial

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Local Institution - 0016

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.